Xerostomia News and Research

RSS
Xerostomia is the medical term for the subjective complaint of dry mouth due to a lack of saliva. Xerostomia is sometimes colloquially called pasties, cottonmouth, drooth, doughmouth or des (like a desert). Xerostomia is also common in smokers.
Cancer patients report less dry mouth after receiving acupuncture treatment

Cancer patients report less dry mouth after receiving acupuncture treatment

Synedgen announces market launch of Moisyn Rinse for treatment of dry mouth symptoms

Synedgen announces market launch of Moisyn Rinse for treatment of dry mouth symptoms

Targeted alpha therapy shows promise in treatment of metastatic prostate cancer

Targeted alpha therapy shows promise in treatment of metastatic prostate cancer

Salivary endoscopy surgery at Loyola cures chronic dry mouth

Salivary endoscopy surgery at Loyola cures chronic dry mouth

IMRT linked to reduced xerostomia and feeding tube dependency in oropharyngeal cancer patients

IMRT linked to reduced xerostomia and feeding tube dependency in oropharyngeal cancer patients

Positive pre-clinical study data of Lamellar Biomedical's Visco-ease published in Supportive Care Journal

Positive pre-clinical study data of Lamellar Biomedical's Visco-ease published in Supportive Care Journal

Researchers use silk fibers to grow stem cells into salivary gland cells

Researchers use silk fibers to grow stem cells into salivary gland cells

People now have powerful new option for relieving dry mouth symptoms

People now have powerful new option for relieving dry mouth symptoms

Acupuncture-like TENS may be effective for treating radiation-induced xerostomia

Acupuncture-like TENS may be effective for treating radiation-induced xerostomia

Merus Labs International acquires rights to manufacture, market specialty pharmaceutical products in multiple countries

Merus Labs International acquires rights to manufacture, market specialty pharmaceutical products in multiple countries

Acacia Pharma reports positive results from APD403 Phase 2 study in CINV

Acacia Pharma reports positive results from APD403 Phase 2 study in CINV

Acacia Pharma begins APD421 Phase 3 study in combination with standard anti-emetics for PONV

Acacia Pharma begins APD421 Phase 3 study in combination with standard anti-emetics for PONV

Asthmatic patients suffering from xerostomia have a poorer level of control disease

Asthmatic patients suffering from xerostomia have a poorer level of control disease

TOSH Program aims to improve oral-systemic health

TOSH Program aims to improve oral-systemic health

Acacia Pharma reports positive results from APD421 Phase 3 studies for management of PONV

Acacia Pharma reports positive results from APD421 Phase 3 studies for management of PONV

Avoiding cSMG during radiation therapy is safe in head and neck cancer patients

Avoiding cSMG during radiation therapy is safe in head and neck cancer patients

Reduction of RT to IB lymph nodes may result in better salivary function in head, neck cancer patients

Reduction of RT to IB lymph nodes may result in better salivary function in head, neck cancer patients

BMG Pharma signs agreement with Samyang Biopharmaceutical to market GelX in South Korea

BMG Pharma signs agreement with Samyang Biopharmaceutical to market GelX in South Korea

Soligenix initiates SGX942 Phase 2 study for treatment of oral mucositis

Soligenix initiates SGX942 Phase 2 study for treatment of oral mucositis

Acacia Pharma begins APD403 Phase II study to prevent chemotherapy-induced nausea & vomiting

Acacia Pharma begins APD403 Phase II study to prevent chemotherapy-induced nausea & vomiting